About the Journal

Focus & Scope of Journal

The Journal of Applied Pharmaceutical Research (JOAPR) publishes original research paper, review papers, short communication in multiple disciplines of Pharmaceutical Sciences. JOAPR is completely devoted towards publications related to Pharmaceutical science. JOAPR also includes evaluation of pharmaceutical excipients & their practical application to research & industry based efforts. The aim of the scientific journal, JOAPR is to present a wide area for the current researchers to share their noble works and ideas. There is no bar on the length of the papers. Full experimental details are expected from authors so that the results can be reproduced.

Subject areas:

Pharmaceutics, Biopharmaceutics & Pharmacokinetics

Pharmaceutical/Medicinal Chemistry, Pharmaceutical Analysis

Computational Chemistry and Molecular Drug Design

Pharmacognosy and Phytochemistry

Herbal drugs/ formulations

Pharmacology, Pharmacy Practice, Clinical & Hospital Pharmacy, Clinical studies in Humans

REVIEW POLICY

Peer review is one of the most important step of the publishing process. It has a fundamental role to play in maintaining the integrity of the published literature and advancing discovery. We are committed to prompt evaluation and publication of fully accepted papers in journals. To maintain a high-quality publication, all submissions undergo a rigorous review process. Characteristics of the peer review process are as follows:

Simultaneous submissions of the same manuscript to different journals is not acceptable
Papers will be refereed by experts as suggested by the editorial board.
All publication decisions are made by the journal's Editors-in-Chief on the basis of the referees' reports. Authors of papers that are not accepted are notified promptly.
All submitted manuscripts are treated as confidential documents. We expect our Board of Reviewing Editors and reviewers to treat manuscripts as confidential material as well.
Editors and reviewers involved in the review process should disclose conflicts of interest resulting from direct competitive, collaborative, or other relationships with any of the authors, and remove oneself from cases in which such conflicts preclude an objective evaluation
Our peer review process is confidential and identities of reviewers cannot be revealed.

The authors may contact us for any clarification in our policy

Publication Procedure

Initial Checks

All submitted manuscripts received by the JOAPR will be checked by Editor-in-Chief to determine whether they are properly prepared according to author instruction. The manuscript will be checked to ascertain that they follow the ethical policies of the journal, including those for human and animal experimentation. Manuscripts that do not fit the journal's ethics policy or do not meet the standards of the journal will be rejected before peer-review. Manuscripts that are not properly prepared will be returned to the authors for revision and resubmission. After these checks, Editor-in-Chief will consult the journal's Editor, Associate Editor, or Advisory Board Member (or an Editorial Board member in case of a conflict of interest) to determine whether the manuscript fits the scope of the journal and whether it is scientifically sound. No judgment on the significance or potential impact of the work will be made at this stage. Reject decisions at this stage will be verified by the Editor-in-Chief.

Peer-Review

Once a manuscript passes the initial checks, it will be assigned to at least two independent subject experts for peer-review. A double blind review is applied where Reviewer's & Authors identity are not revealed to each other. Only Editor-in-Chief is aware of identity of both.

Potential reviewers suggested by the authors during submission process may also be considered. Reviewers should not have published with any of the co-authors during the past five years and should not currently work or collaborate with any of the institutions of the co-authors of the submitted manuscript.

Editorial Decision and Revision

All the articles, reviews and communications published in JOAPR go through the peer-review process and receive at least two reviews. The Reviewer will communicate the decision to the Editor-in-Chief with following points

Accept after Minor Revisions: The paper is in principle accepted after revision based on the reviewer's comments. Authors are given five days for minor revisions.

Reconsider after Major Revisions: The acceptance of the manuscript would depend on the revisions. The author needs to provide a point by point response or provide a rebuttal if some of the reviewer's comments cannot be revised. Usually, only one round of major revisions is allowed. Authors will be asked to resubmit the revised paper within a suitable time frame, and the revised version will be returned to the reviewer for further comments.
Reject and Encourage Resubmission: If additional experiments are needed to support the conclusions, the manuscript will be rejected and the authors will be encouraged to re-submit the paper once further experiments have been conducted.
Reject: The article has serious flaws, and/or makes no original significant contribution. No offer of resubmission to the journal is provided.

All reviewer comments should be responded to in a point-by-point fashion by Authors. Where the authors disagree with a reviewer, they must provide a clear response.

Author Appeals

Authors may appeal a rejection by sending an e-mail to the Editorial Office of the journal. The appeal must provide a detailed justification, including point-by-point responses to the reviewers' and/or Editor's comments. The Editor-in-Chief will discuss the manuscript and related information with Editorial Board members. The Editorial Board will then give an advisory recommendation on the manuscript and may recommend acceptance, further peer-review, or uphold the original rejection decision. A reject decision at this stage is final and cannot be reversed.

Publication Ethics

To preserve the honesty, excellence, and reliability of the research published in the Journal of Applied Pharmaceutical Research, publication ethics are crucial. The obligations of editors, writers, and reviewers in respecting ethical standards are described in these principles. The Code of Conduct and Best-Practice Guidelines for Journal Editors (Committee on publishing Ethics, 2011) serve as the foundation for the publishing ethics and malpractice statement of the Journal of Applied Pharmaceutical Research (JOAPR). For COPE guidelines, please follow the website of COPE https://publicationethics.org/

Role of the Editor

Editorial Independence

Editors are in charge of preserving the journal's editorial independence and making sure that no other forces, such as business interests or political pressure, affect editorial choices.
Editors must state any conflicts of interest and abstain from reviewing submissions in certain situations.

Fair and Impartial Review

Editors must supervise an impartial and fair peer-review procedure. No matter the authors' name, nationality, or institutional connection, manuscripts should be judged on their scientific value, originality, and significance.
Editors should choose reviewers who are knowledgeable and capable of offering frank and constructive criticism.

Confidentiality

Editors must uphold the privacy of submitted papers and safeguard the identity of authors and reviewers while the work is being reviewed.
No personal benefit should be made from any sharing of confidential information collected during the evaluation process.

Publishing Decision

Editors are in charge of deciding whether or not to publish an article in accordance with the guidelines and scope of the journal, the suggestions of the reviewers, and the scientific quality of the paper.
Personal prejudices or conflicts of interest shouldn't be used as grounds for accepting or rejecting manuscripts.

Ethical Oversight

Editors must keep an eye out for any possible ethical problems, such as data manipulation, plagiarism, and ethical lapses, and must respond appropriately when they are discovered.
When there is suspicion of misbehaviour, editors should collaborate with writers to address the issues openly. When mistakes or ethical breaches are found in published work, editors should assist the release of corrections, retractions, or clarifications. Corrections should be done right away, and retractions should only be issued when required.

Role of the Author

Originality and Plagiarism

Authors must make sure that their work is unique and correctly credited. Self-plagiarism is prohibited, as is plagiarism in any other form.
Proper credit must be given to all material, data, and previously published works.

Authorship and Contributorship

Authors must satisfy the requirements for authorship based on significant contributions to the study and paper.
All authors or proper acknowledgements should be provided for all contributors.
Honorary authorship and ghostwriting are not encouraged.

Research Ethics

Authors should conduct their studies in conformity with moral principles, such as the Helsinki Declaration for human research and the appropriate regulations for animal research.
Human participants' informed permission is required, and animal research must have ethical clearance.

Financial, personal, or professional conflicts of interest that can affect their work or the way their findings are interpreted must be disclosed by authors. Reporting transparency is essential.

Transparency and Data Sharing

Authors should make available all pertinent data and details to enable others to duplicate their study.
Datasets should, if feasible, be made accessible and shared in compliance with applicable laws.

Timeliness and Cooperation

Authors must be on time and cooperative when editors and reviewers ask for changes or more information.
Editorial collaboration is necessary for timely publishing.

Ethical Reporting

Authors should accurately and truthfully present their findings, including both favourable and unfavourable outcomes.
It is immoral to manipulate statistics or report just certain information.

Role of the Reviewer

Confidentiality

Maintaining the review process' anonymity requires reviewers to keep all information regarding papers, including their existence, private from anyone not directly participating in the peer-reviewing process.

Objectivity and Constructiveness

Reviewers should offer objective, helpful, and unbiased input on the manuscript's advantages and disadvantages, and they should be honest about any personal biases or conflicts of interest that could affect their objectivity when they communicate with the editor.

Timeliness

Reviewers need to finish their reviews by the predetermined deadline. They must immediately notify the editor if they will not make the deadline.

Ethical Considerations

Reviewers should notify the editor of any ethical issues they see in the article, such as plagiarism, ethical violations, or data manipulation. They should also refrain from using concepts or data from the paper for their own study without the author's consent.

Conflict of Interest

Reviewers must disclose any possible conflicts of interest they may have with the manuscript they are reviewing, and they must alert the editor if a conflict materialises.

Suggestions for the Editor

Reviewers should make suggestions to the editor that are specific, well-supported, and should state whether the manuscript should be accepted, changed, or rejected. They should also refrain from making disparaging or libellous remarks.

The legitimacy and dependability of the Journal of Applied Pharmaceutical Research are largely dependent on these publishing ethical principles. The ethical conduct of research and the publication process in the field of pharmaceuticals are ensured by the authors', reviewers', and editors' adherence to these norms. When rules are broken, remedial measures may be taken, such as submissions being rejected, articles being retracted, or reports being made to the proper authorities.

Allegation of research misconduct

Research misconduct refers to fabrication, falsification, citation manipulation, or plagiarism in the creation, performance, or review of research, the drafting of an article by authors, or in the reporting of research results. Editors have a duty to uphold the truth and integrity of the scientific record when authors are proven to have engaged in significant misconduct concerning research or other publications that have been published in scientific journals.

The Editors and Editorial Board will apply the COPE's best practises where there is a suspicion of misconduct to help them resolve the issue and deal equitably with the infraction. Among other things, the Editors will look into the claim. Any paper that is submitted but is later discovered to include such misbehaviour will be disregarded. A retraction can be published and will be linked to the original article in circumstances where a published study is discovered to include such wrongdoing.

Finding out if the claim is true and assessing whether it fits the description of research misconduct is the first stage. In this first phase, it is also necessary to look into any potential conflicts of interest that may exist between the people who are accused of misbehaviour.

The charges are sent to the corresponding author, who is then asked to answer in-depth on behalf of all co-authors, if there is a chance that there was scientific misconduct or other significant research abnormalities. After the reply has been received and assessed, it may be subjected to further scrutiny and consultation with subject-matter experts (such as statisticians). Clarifications, more analyses, or both, published as letters to the editor, frequently including a correction notice and revision to the published article, are adequate in situations when it is doubtful that wrongdoing has taken place.

Institutions are required to look into claims of scientific misconduct properly and completely. The veracity of the scientific record is ultimately a responsibility that falls on authors, journals, and organisations. The JOAPR will continue to carry out its duties of ensuring the validity and integrity of the scientific record by responding appropriately to concerns about scientific misconduct and taking necessary actions based on evaluation of these concerns, such as corrections, retractions with replacement, and retractions.

Grievances and Appeals

JOAPR have a defined process for dealing with complaints about the publication, editorial staff, editorial board, or publisher. The complaints will be explained to the recognised individual with regard to the complaint case. The complaints' scope includes anything pertaining to the journal business process, such as the editorial process, finding citation manipulation, unfair editors/reviewers, peer-review manipulation, etc. The processing of the complaint cases shall follow COPE guidelines.

Ethical lapse

To comply with ethical guidelines for research involving human and animal subjects, the author must explicitly identify any substances, people, animals, techniques, or equipment that have any unique dangers inherent in their usage in the publication. The association or legal organisation must, if requested, have legal and ethical approval from the authors.

Authors should explicitly explain whether or not the research will use secure storage for any private data or information if it does.

LICENSE AGREEMENT

In submitting an article to Journal of Applied Pharmaceutical Research (JOAPR) I certify that:

I am authorized by my co-authors to enter into these arrangements.
I warrant, on behalf of myself and my co-authors, that:

The article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights;
I am/we are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to JOAPR are not in breach of any other obligation;
The article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy;
I/we have taken due care to ensure the integrity of the article. To my/our - and currently accepted scientific - knowledge all statements contained in it purporting to be facts are true and any formula or instruction contained in the article will not, if followed accurately, cause any injury, illness or damage to the user.

I, and all co-authors, agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution-NonCommercial 4.0 International License
I, and all co-authors, agree that, if the article is editorially accepted for publication in Journal of Applied Pharmaceutical Research (JOAPR) data included in the article shall be made available under the Creative Commons 1.0 Public Domain Dedication waiver, unless otherwise stated. For the avoidance of doubt it is stated that sections 1, 2, and 3 of this license agreement shall apply and prevail.

PLAGIARISM POLICY

"Plagiarism is the use of others' published and unpublished ideas or words (or other intellectual property) without attribution or permission, and presenting them as new and original rather than derived from an existing source. The intent and effect of plagiarism is to mislead the reader as to the contributions of the plagiarizer. This applies whether the ideas or words are taken from abstracts, research grant applications, Institutional Review Board applications, or unpublished or published manuscripts in any publication format. Plagiarism is scientific misconduct and should be addressed as such.

Self-plagiarism refers to the practice of an author using portions of their previous writings on the same topic in another of their publications, without specifically citing it formally in quotes. This practice is widespread and sometimes unintentional, as there are only so many ways to say the same thing on many occasions, particularly when writing the methods section of an article. Although this usually violates the copyright that has been assigned to the publisher, there is no consensus as to whether this is a form of scientific misconduct, or how many of one's own words one can sue before it is truly "plagiarism." Probably for this reason self-plagiarism is not regarded in the same light as plagiarism of ideas and words of other individuals. If journals have developed a policy on this matter, it should be clearly stated for authors."

Direct plagiarism is the plagiarism of the text. Mosaic plagiarism is the borrowing of ideas and opinions from an original source and a few verbatim words or phrases without crediting the author.

Authors can adhere to the following steps to report plagiarism:

Inform the editor of the journal where a plagiarized article is published.
Send original and plagiarized articles with plagiarized part highlighted.
If evidence of plagiarism is convincing, editor should arrange for a disciplinary meeting.
Editor of the journal where the plagiarized article should communicate with the editor of the journal containing the original article to rectify the matter.
The plagiarist should be asked to provide an explanation.
In case of non response in the stipulated time or an unsatisfactory explanation, the article should be permanently retracted.
Author should be blacklisted and debarred for submitted an article to a particular journal for at least 6 months.
The concerned head of the institution has to be notified.

POLICIES ON CONFLICT OF INTEREST, HUMAN RIGHTS, ANIMAL RIGHTS

Human and animal rights

All Researcher must have carry out research within an appropriate ethical framework. If there is suspicion that work has not taken place within an appropriate ethical framework, Editors will follow the Misconduct policy and may reject the manuscript, and/or contact the author(s)â€™ institution or ethics committee. On rare occasions, if the Editor has serious concerns about the ethics of a study, the manuscript may be rejected on ethical grounds, even if approval from an ethics committee has been obtained.

Research involving human subjects, human material, or human data, must have been performed in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee. A statement detailing this, including the name of the ethics committee and the reference number where appropriate, must appear in all manuscripts reporting such research. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript with proper justification. Further information and documentation to support this should be made available to Editors on request. Manuscripts may be rejected if the Editor considers that the research has not been carried out within an appropriate ethical framework. In rare cases, Editors may contact the ethics committee for further information.

If a study has not been submitted to an ethics committee prior to commencing, retrospective ethics approval usually cannot be obtained and it may not be possible to consider the manuscript for peer review. How to proceed in such cases is at the Editor(s)' discretion.

Authors reporting the use of a new procedure or tool in a clinical setting, for example as a technical advance or case report, must give a clear justification in the manuscript for why the new procedure or tool was deemed more appropriate than usual clinical practice to meet the patient's clinical need. Such justification is not required if the new procedure is already approved for clinical use at the authors' institution. Authors will be expected to have obtained ethics committee approval and informed patient consent for any experimental use of a novel procedure or tool where a clear clinical advantage based on clinical need was not apparent before treatment.

Informed consent

For all research involving human subjects, informed consent to participate in the study should be obtained from participants (or their parent or guardian in the case of children under 16) and a statement to this effect should appear in the manuscript.

For all manuscripts that include details, images, or videos relating to individual participants, written informed consent for the publication of these must be obtained from the participants (or their parent or legal guardian in the case of children under 16) and a statement to this effect should appear in the manuscript. If the participant has died, then consent for publication must be sought from the next of kin of the participant. This documentation must be made available to Editors on request, and will be treated confidentially. In cases where images are entirely unidentifiable and there are no details on individuals reported within the manuscript, consent for publication of images may not be required. The final decision on whether consent to publish is required lies with the Editor.

A statement detailing compliance with relevant guidelines and/or ethical approval (including the name of the ethics committee and the reference number where appropriate) must be included in the manuscript. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption and the reasons for the exemption). The Editor will take account of animal welfare issues and reserves the right to reject a manuscript, especially if the research involves protocols that are inconsistent with commonly accepted norms of animal research. In rare cases, Editors may contact the ethics committee for further information.

Conflict of Interest

Authors are required to disclose all sources of institutional, private and corporate financial support for their study. Donors of materials (for free or at a discount from current rates) should be named in the source of funding and their location (town, state/county, country) included. Other donors will be identified in the text. If no funding has been available other than that of the author's institution, this should be specified upon submission. Authors are also required to disclose any potential conflict of interest. These include financial interests (for example patent, ownership, stock ownership, consultancies, speaker's fee,) or provision of study materials by their manufacturer for free or at a discount from current rates. Author's conflict of interest (or information specifying the absence of conflicts of interest) and the sources of funding for the research will be published under a separate heading entitled â€œConflict of Interest and Sources of Funding Statements. Any experiments involving animals must be demonstrated to be ethically acceptable and where relevant conform to national guidelines for animal usage in research

PRIVACY POLICY

JOAPR is committed to protect users' privacy online. This privacy policy sets forth our practices regarding collection, use and disclosure of information collected through the JOAPR website.

In order to offer the best possible service to users, the website may automatically collect certain information from your web browser regarding your use of the site. The information will be recorded in web server log files. We may use the information to help us understand more about how our web site is used, to recognize patterns of usage of the site, to improve our site. While we may track site usage, we in no way relate this usage to any users in particular.

We may use cookies to collect information to help us learn your preferences, but we don`t use cookies to collect and store individually-identifiable information. You can modify your browser`s privacy preferences, if you wish to prevent your browser from accepting certain cookies or wish the browser to require your consent before a new cookie is placed in your browser.

Registration on JOAPR website is mandatory for submission of manuscript, review of submitted manuscript by Reviewer. However, registration is not at all required for viewing its content or simply reading the published article. During registration we collect some personal information such as your name, email address, affiliation, research interests, among others. This information enables us to develop and customize products to better meet your needs and preferences. We may contact registered users from time to time to draw your attention to information that may be of interest to you. You may opt out from receiving such email when at any time by contacting our customer service.

Collection of users information for commercial use is strictly not permitted. We will not sell or share any personal information to any third parties without the explicit consent of the user. We endeavor to keep your personal information confidential and protected against unauthorized access through the use of appropriate safeguards.

This web site may contain links to other websites that are not with our control. If you link to their sites, they may contain privacy policies that are different from this privacy policy. Such sites are not covered by this privacy policy.

We reserves the right to disclose any information if we are required to do so by law or to comply with legal process, if we believe it is necessary to take action regarding illegal activities or to protect our rights, or if JOAPR is acquired by, transferred to or merged with another company.

We reserve the right to change this policy at any time without notice. Any changes to this policy will be posted on this web page.

ADVERTISEMENT POLICY

Journal of Applied Pharmaceutical Research (JOAPR) does not accept advertising on its official website, https://www.japtronline.com. However, we accept advertisements on other official JOAPR (social media) pages. JOAPR neither endorses the advertised company or product nor allows advertising to affect editorial decisions or content.

Advertising Acceptance

JOAPR reserves the right to refuse any advertisement incompatible with our mission. JOAPR will adhere to all ethical and commonly accepted advertising practices and ensure that its practices conform to its Vision and mission. The following types of advertisements are prohibited

Political and religious advertisements
Advertisements that claim to offer a miracle cure or method
Advertisements for alcohol, tobacco or any related product(s)
Advertisements for weapons, firearms, ammunition and fireworks
Advertisements for pornography and related materials and services
Advertisements that make unsubstantiated health claims for the products advertised

Advertising Policy

Advertisements will always be allowed only after approval of JOAPR/
Advertisements, icons, and logos must be distinguishable from editorial content.
Advertisers may be required to submit supporting documentation to substantiate claims.
Advertisements may not imply endorsement by the JOAPR
Neither advertisers nor their agents may collect personal information from any user viewing the JOAPR website except with the user's knowledge and permission and only after giving the user substantive information about the uses to which the information will be put.

Advertising revenue supports Authors with limited funds to pay Article Processing Charges (APC).

For questions about online advertising on the JOAPR, contact the sales team at +917987014131 or japr.editor@gmail.com

WAIVER OF ARTICLE PROCESSING CHARGE (APC)

The publication of papers submitted to Journal of Applied Pharmaceutical Research (JOAPR) incurs an article processing fee (APC) of Rs. 11800/- for Indian Authors & $550 (US Dollar) for Foreign Authors. Authors from SAARC countries can pay in Indian Currency.

Journal of Applied Pharmaceutical Research (JOAPR) do not want fees to prevent the publication of worthy work. JOAPR also maintains a fund to waive the fee for authors in developing parts of the world whose university or institute is unable to pay, or who have not received sufficient financial support from funding agencies.

We offer a complete or partial/full fee waiver on a case-by-case basis for individual authors or author groups from countries in the developing world, but only if the request for a waiver has been sent to japr.editor@gmail.com after submission of the manuscript.

The corresponding author must send the following information in the letter of request, together with any supporting documents:

Manuscript title
Names and titles of all authors
Institutional affiliations of all authors
Type of waiver requested: Partial (indicate the amount you can pay in INR/USD) or Full
Reason for waiver application

Click here to Submit the form online

Applications that do not contain this information will not be evaluated. The decision of Board member will be informed to author. The decision of Editor-in-Chief will be final and cannot be challenged

About the Journal

Make a Submission